O Butenandt

1.5k total citations
77 papers, 1.1k citations indexed

About

O Butenandt is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, O Butenandt has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Molecular Biology and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in O Butenandt's work include Growth Hormone and Insulin-like Growth Factors (34 papers), Sexual Differentiation and Disorders (17 papers) and Birth, Development, and Health (7 papers). O Butenandt is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (34 papers), Sexual Differentiation and Disorders (17 papers) and Birth, Development, and Health (7 papers). O Butenandt collaborates with scholars based in Germany, France and Switzerland. O Butenandt's co-authors include F. Bidlingmaier, Dietrich Knorr, H. P. Schwarz, O Linderkamp, K Riegel, Björn Jonsson, Hans‐Peter Schwarz, Pierre Chatelain, Kerstin Albertsson‐Wikland and Helmut Holtmann and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Pediatrics and Drugs.

In The Last Decade

O Butenandt

71 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Butenandt Germany 19 596 391 272 258 219 77 1.1k
Seizo Suwa Japan 19 632 1.1× 740 1.9× 206 0.8× 415 1.6× 155 0.7× 80 1.4k
Mark Stene United States 16 598 1.0× 306 0.8× 147 0.5× 214 0.8× 349 1.6× 23 1.2k
Piero Pirazzoli Italy 25 814 1.4× 686 1.8× 301 1.1× 430 1.7× 157 0.7× 64 1.7k
Giovanna Municchi Italy 17 598 1.0× 511 1.3× 184 0.7× 416 1.6× 288 1.3× 32 1.1k
Margaret H. MacGillivray United States 28 1.0k 1.7× 531 1.4× 324 1.2× 517 2.0× 116 0.5× 83 1.8k
B Boscherini Italy 23 779 1.3× 659 1.7× 193 0.7× 460 1.8× 165 0.8× 87 1.6k
P Malvaux Belgium 23 970 1.6× 708 1.8× 360 1.3× 439 1.7× 208 0.9× 77 1.7k
Giorgio Radetti Italy 18 634 1.1× 347 0.9× 249 0.9× 319 1.2× 144 0.7× 57 1.2k
P Rochiccioli France 25 1.0k 1.7× 562 1.4× 474 1.7× 512 2.0× 101 0.5× 111 1.7k
W. F. Blum Germany 18 808 1.4× 387 1.0× 209 0.8× 232 0.9× 141 0.6× 31 1.6k

Countries citing papers authored by O Butenandt

Since Specialization
Citations

This map shows the geographic impact of O Butenandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Butenandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Butenandt more than expected).

Fields of papers citing papers by O Butenandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Butenandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Butenandt. The network helps show where O Butenandt may publish in the future.

Co-authorship network of co-authors of O Butenandt

This figure shows the co-authorship network connecting the top 25 collaborators of O Butenandt. A scholar is included among the top collaborators of O Butenandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Butenandt. O Butenandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bechtold, Susanne, et al.. (2001). Persistent Papilledema in Ulirich-Turner Syndrome Treated with Growth Hormone. Clinical Pediatrics. 40(11). 629–631. 1 indexed citations
2.
Haverkamp, F., Joachim Wölfle, Klaus Zerres, et al.. (1999). Growth Retardation in Turner Syndrome: Aneuploidy, Rather Than Specific Gene Loss, May Explain Growth Failure. The Journal of Clinical Endocrinology & Metabolism. 84(12). 4578–4582. 26 indexed citations
3.
Rekers-Mombarg, L.T.M., G. Massa, J.M. Wit, et al.. (1998). Growth hormone therapy with three dosage regimens in children with idiopathic short stature. The Journal of Pediatrics. 132(3). 455–460. 32 indexed citations
4.
Pérel, Yves, O Butenandt, Robert Saura, et al.. (1998). Oesophageal atresia, VACTERL association: Fanconi's anaemia related spectrum of anomalies. Archives of Disease in Childhood. 78(4). 375–376. 17 indexed citations
5.
Butenandt, O, et al.. (1998). Childhood onset of GH deficiency:Reassessment of GH status and effects of substitution. Growth Hormone & IGF Research. 8. 9–13. 2 indexed citations
6.
Yang, Yu‐Shih, et al.. (1996). Opposite regulation of IGF-I and IGF-I receptor mRNA and concomitant changes of GH receptor and IGF-II/M6P receptor mRNA in human IM-9 lymphoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1310(3). 317–324. 11 indexed citations
7.
Butenandt, O, et al.. (1996). Endocrine disorders in septo-optic dysplasia (De Morsier syndrome) — evaluation and follow up of 18 patients. European Journal of Pediatrics. 155(3). 179–184. 46 indexed citations
9.
Butenandt, O, et al.. (1995). Final height and predicted height in boys with untreated constitutional growth delay. European Journal of Pediatrics. 154(8). 627–632. 60 indexed citations
10.
Butenandt, O. (1989). Diagnostic Value of Growth Hormone‐Releasing Hormone Tests in Short Children. Acta Paediatrica. 78(s349). 93–99. 8 indexed citations
11.
Butenandt, O, et al.. (1986). Single and repeated testing of growth hormone secretory capacity in hypopituitarism using growth hormone releasing factor. European Journal of Endocrinology. 113(4_Suppl). S118–S122. 3 indexed citations
12.
Holtmann, Helmut, et al.. (1983). Modulation of lymphoproliferation by human growth hormone. European Journal of Pediatrics. 140(1). 47–50. 47 indexed citations
13.
Bidlingmaier, F., et al.. (1980). 17-ketosteroid reductase deficiency — plasma steroids and incubation studies with testicular tissue. European Journal of Endocrinology. 94(3). 397–403. 9 indexed citations
14.
Butenandt, O, et al.. (1979). [Maldescensus testis, therapy and prognosis].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 97(34). 1453–5. 1 indexed citations
15.
Butenandt, O, et al.. (1978). [Diagnostic means to exclude deficient secretion of growth hormone in paediatric practice (author's transl)].. PubMed. 190(5). 460–4. 1 indexed citations
16.
Butenandt, O, et al.. (1976). [Growth hormone determinations in children with rheumatoid arthritis and Still's syndrome (proceedings)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35 Suppl 4. suppl 47–53. 1 indexed citations
17.
Benkert, Otto, M. B. Bender, F. Bidlingmaier, & O Butenandt. (1976). Effect of p-chlorophenylalanine (PCPA) on pituitary hormones and testosterone in the human.. PubMed. 26(7). 1369–71. 2 indexed citations
18.
Butenandt, O, et al.. (1976). Mean 24-hour growth hormone and testosterone concentrations in relation to pubertal growth spurt in boys with normal or delayed puberty. European Journal of Pediatrics. 122(2). 85–92. 21 indexed citations
19.
Butenandt, O, et al.. (1974). Growth hormone studies in patients with rheumatoid arthritis with or without glucocorticoid therapy. European Journal of Pediatrics. 118(1). 53–62. 13 indexed citations
20.
Souvatzoglou, A., et al.. (1973). THE FUNCTIONAL SIGNIFICANCE OF "EPISODIC" LH SECRETION. European Journal of Endocrinology. 71(4_Suppl). S42–S42.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026